Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02167022 : Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
PhaseN/A
AgesMin: 12 Months Max: 36 Months
Eligibility
Inclusion Criteria:

1. Age: 12 to 36 months of age (The diagnosis of CP is often uncertain under the age of
12 months. The cutoff at 36 months is to have a population of young children when the
brain is most "plastic" and most susceptible to reorganization).

2. Diagnosis: Diagnosis of spastic CP confirmed by a pediatric neurologist or pediatric
rehabilitation specialist.

3. Etiology: The insult to the central nervous system that caused the motor dysfunction
must have occurred during gestation or within one year after birth independent of
gestational age.

4. Disease severity level: Gross Motor Function Classification System (GMFCS) levels I,
II and III.

Exclusion Criteria:

1. Diagnosis: Diagnosis of CP secondary to neuronal migration.

2. Co-morbidities: Medical conditions that may prevent the administration of
rehabilitation therapies at the intensity required by the study, or that may
compromise the study ability to maintain blindness, or that have a co-morbidity not
typically associated with CP (i.e. cancer, cystic fibrosis).

3. Co-interventions: Anticipated pharmacological intervention or procedure or
participation in other studies that may interfere with this study.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02167022      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740